source
- STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived earlyIn data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.STAT · 18d ago↗ source
- Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStarGilead Sciences has picked up a new inflammatory disease program from China’s PepStar Therapeutics to pair with the Phase 2 inflammatory bowel disease asset emvistegrast.BioSpace · 19d ago↗ source
- STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sectorA new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.